US Corporate Board Director Changes SEC Filings — December 21, 2025

22-12-2025

Fastenal Co (FAST) filed Form 8-K on 2025-12-22 disclosing an officer change under Item 5.02, with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specifics on officer name, position, appointment/resignation, or reasons provided (all NOT_DISCLOSED). Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

• ·Officer change reported (Item 5.02); key details like position (CEO/CFO/etc.), type (appointment/resignation), reason, and timing NOT_DISCLOSED.
• ·Reg FD disclosure (Item 7.01) flags potential material information shared.
• ·Routine SEC compliance filing; no board outcomes, governance impacts, or succession signals detailed.

22-12-2025

Telomir Pharmaceuticals, Inc. filed an 8-K on December 22, 2025, under Item 5.02 disclosing an officer change event. No specifics on position, individual, appointment/departure, or reasons are provided. Analysis limited to filing header; all details NOT_DISCLOSED.

• ·Item 5.02 filing indicates departure, election, appointment, or compensatory arrangement for officers/directors
• ·Filed timely (within 4 business days per SEC rules)
• ·No quantitative data, names, or reasons extracted; critical details missing

22-12-2025

MIRA PHARMACEUTICALS, INC. filed a Form 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the affected position, nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary. Analysis is constrained to the fact of disclosure with all other elements NOT_DISCLOSED.

• ·Item 5.02 officer change filing (AccNo: 0001493152-25-028619)
• ·Filed December 22, 2025; sector not specified
• ·No names, positions, reasons, or quantitative data (e.g., shares, compensation) disclosed

22-12-2025

Driven Brands Holdings Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosed items; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 indicates an officer or director change event, but position (e.g., CEO/CFO), type (appointment/resignation), and reasons are NOT_DISCLOSED.
• ·Items 7.01 and 9.01 suggest additional Reg FD disclosure and exhibits, but content details NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

22-12-2025

COTY INC. filed a Form 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Item 9.01 references financial statements and exhibits, but contents are NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Timely SEC disclosure (within 4 business days requirement)
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

22-12-2025

Silence Therapeutics plc filed an 8-K on December 22, 2025, under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided. Analysis is limited to metadata; all key facts such as leadership changes or governance impacts are NOT_DISCLOSED.

• ·Item 5.02 event: Covers officer/director departures, appointments, or compensation
• ·Filed timely on 2025-12-22 per SEC requirements
• ·No names, positions, reasons, or financial metrics disclosed

22-12-2025

Better Home & Finance Holding Co filed an 8-K on 2025-12-22 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment) and other events under Item 8.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Critical information such as key position affected, reasons, and financial metrics is NOT_DISCLOSED.

• ·Item 5.02 indicates officer/director change or compensatory arrangements, details NOT_DISCLOSED
• ·Item 8.01 reports other events, details NOT_DISCLOSED
• ·Filing dated 2025-12-22, AccNo: 0001628280-25-058397, sector not specified

22-12-2025

NeuroOne Medical Technologies Corp filed an 8-K on 2025-12-22 disclosing an officer change under Item 5.02 (Departure/Election of Officers), Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all other leadership/governance details NOT_DISCLOSED.

• ·Item 5.02 indicates officer change event (appointment, departure, or compensatory arrangement), but specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD disclosure filed, content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

22-12-2025

Transcode Therapeutics, Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit facts beyond item disclosures.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors, but key position, type, and reason NOT_DISCLOSED
• ·Item 7.01 for Regulation FD disclosure, content NOT_DISCLOSED
• ·Item 9.01 lists exhibits, details NOT_DISCLOSED; no quantitative data (transaction value, shares, percentages, financial metrics) extracted

22-12-2025

CS Disco, Inc. filed an 8-K on December 22, 2025, under Item 5.02 disclosing departure of directors/officers, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.

• ·Item 5.02 covers officer/director changes or compensatory arrangements (details NOT_DISCLOSED)
• ·Item 9.01 includes financial statements/exhibits (contents NOT_DISCLOSED)
• ·Event classified as Officer Change; sector not specified

22-12-2025

Blackbaud Inc filed an 8-K on December 22, 2025, under Item 5.02 disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, with Item 9.01 for exhibits. No specific details on position, person, reason, or quantitative data are provided in the summary. Analysis limited to filing metadata; critical facts NOT_DISCLOSED.

• ·Item 5.02: Officer change or compensatory arrangements mentioned, but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·Filed timely on 2025-12-22 per SEC 8-K requirements
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED

22-12-2025

Prudential Financial Inc disclosed an officer change via Form 8-K filed on December 22, 2025, under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), with additional Reg FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the summary. This is a standard SEC disclosure without evident material impact.

• ·Item 5.02 indicates officer change event (details NOT_DISCLOSED)
• ·Filed timely on 2025-12-22 per SEC 8-K requirements
• ·No quantitative data (transaction values, shares, percentages: NOT_DISCLOSED)

22-12-2025

Amprius Technologies, Inc. filed an 8-K on December 22, 2025 (AccNo: 0001899287-25-000048), disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. Analysis limited to filing metadata; all key change details NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement
• ·Filed 2025-12-22; sector NOT_DISCLOSED
• ·No names, positions, appointment/resignation status, or reasons stated

22-12-2025

Tetra Tech Inc filed a Form 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details on the affected position, appointment or resignation, reasons, or any quantitative data are NOT_DISCLOSED. This is a routine SEC disclosure with no explicit facts on impact.

• ·Item 5.02 covers officer/director departures, elections, appointments, or compensatory arrangements
• ·Item 8.01 discloses other events; Item 9.01 lists exhibits
• ·No names, positions, reasons, numerical values, or financial metrics mentioned

22-12-2025

An 8-K filing dated December 22, 2025 (AccNo: 0001193125-25-327931) discloses an officer change under Item 5.02, but provides no details on the position affected, individual involved, appointment/resignation status, reason, or any quantitative data. Analysis is severely limited by absence of key facts from the filing. No governance, succession, or market impact can be reliably assessed.

• ·Event Type: Officer Change (Item 5.02)
• ·Filing Date: 2025-12-22; no company name, position, or reason specified
• ·Quantitative data (transaction value, shares, percentages): NOT_DISCLOSED

22-12-2025

Tennessee Valley Authority filed an 8-K on December 22, 2025 (AccNo: 0001376986-25-000060), disclosing Item 5.02 on officer changes, including departures, elections, appointments, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the available information. Analysis is limited due to lack of explicit filing content beyond the item header.

• ·Item 5.02 filing indicates officer change event, but key details (position, appointment/resignation, reasons) are NOT_DISCLOSED.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned.
• ·TVA is a government-owned entity, not a publicly traded equity, limiting direct market impact.

22-12-2025

Liberty Star Uranium & Metals Corp. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers), other events under Item 8.01, and exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, or quantitative impacts are provided in the filing summary. All numerical values (transaction value, share count, percentages, financial metrics) are NOT_DISCLOSED.

• ·Item 5.02 indicates officer change event, but key position, type (appointment/resignation), and reasons NOT_DISCLOSED
• ·Filed timely per SEC 8-K requirements (within 4 business days)
• ·No board composition, succession, or governance details specified; quantitative data NOT_DISCLOSED

22-12-2025

Donegal Group Inc. filed an 8-K on December 22, 2025, disclosing an event under Item 5.02 related to departure of directors/officers, elections, appointments, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data are provided in the filing summary. Analysis is limited to the Item 5.02 reference, with all other key facts NOT_DISCLOSED.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·Filed 2025-12-22 (AccNo: 0001140361-25-046361)
• ·Sector NOT_DISCLOSED; no names, positions, reasons, or financial metrics mentioned

22-12-2025

SB Financial Group, Inc. filed an 8-K on December 22, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are disclosed in the provided filing summary. Item 9.01 references financial statements and exhibits, but no quantitative data or further context is available.

• ·Item 5.02 disclosure indicates officer-related change (departure, election, appointment, or compensatory arrangement)
• ·Filed within SEC 8-K requirements (within 4 business days)
• ·No details on key position (e.g., CEO/CFO), reason, or board impact provided; all specifics NOT_DISCLOSED

22-12-2025

HEICO CORP filed an 8-K on 2025-12-22 under Item 5.02 disclosing a departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, with Item 9.01 listing financial statements/exhibits. No specific names, positions, reasons, or quantitative details are stated in the provided filing summary. Analysis limited to headers; all other data NOT_DISCLOSED.

• ·Item 5.02 covers officer/director changes or compensatory arrangements (FACTS from filing).
• ·Item 9.01 references exhibits (FACTS from filing).
• ·No details on key position, appointment/resignation type, reasons, or quantitative metrics (NOT_DISCLOSED).

22-12-2025

Zions Bancorporation, National Association filed a Form 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, appointment/resignation status, reasons, or quantitative data are disclosed in the summary.

• ·Item 5.02 filing indicates officer or director change, potentially involving compensatory arrangements
• ·Timely SEC disclosure on 2025-12-22 per Form 8-K requirements
• ·All specifics (names, roles, reasons, numbers) NOT_DISCLOSED; exhibits mentioned but not detailed

22-12-2025

Nutanix, Inc. filed an 8-K on December 22, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the filing summary. This appears to be a standard SEC disclosure with limited visibility into implications.

• ·Item 5.02: Departure/Election/Appointment of officers or compensatory arrangements
• ·Filed 2025-12-22; AccNo: 0001193125-25-328770
• ·No names, positions, reasons, or numerical data explicitly stated

22-12-2025

TFS Financial CORP filed a Form 8-K on December 22, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or quantitative data are provided in the summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 disclosure: Officer/director change or compensatory arrangement
• ·Filing date: 2025-12-22; AccNo: 0001381668-25-000109
• ·All specifics (positions, names, reasons, quantitative data): NOT_DISCLOSED

22-12-2025

RCM Technologies, Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02, results of a shareholder vote under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, nature of change, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content from the filing.

• ·Item 5.02: Officer change (departure, election, or appointment) - specifics NOT_DISCLOSED
• ·Item 5.07: Shareholder vote results - outcomes NOT_DISCLOSED
• ·No numerical data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Sector not specified

22-12-2025

Atlassian Corp filed a Form 8-K on December 22, 2025 (AccNo: 0001650372-25-000072), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided in the summary. This is a routine SEC disclosure requiring further review of the full filing for materiality.

• ·Item 5.02: Officer/director change or compensatory arrangements
• ·Filed December 22, 2025; Size 141 KB
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

22-12-2025

Minerva Neurosciences, Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), submission of matters to a vote under Item 5.07, and financial statements/exhibits under Item 9.01. Specific details on positions affected, reasons for change, votes, or quantitative data are NOT_DISCLOSED in the provided summary. Analysis is limited to filing structure without substantive content.

• ·Item 5.02 indicates officer/director departure, election, appointment, or compensatory arrangements (details NOT_DISCLOSED)
• ·Item 5.07 covers submission of matters to a vote of security holders (outcomes NOT_DISCLOSED)
• ·Item 9.01 lists financial statements and exhibits (contents NOT_DISCLOSED)

22-12-2025

Pioneer Bancorp, Inc./MD filed an 8-K on 2025-12-22 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and exhibits under Item 9.01. No specific details on positions, individuals, reasons, or quantitative data are provided. Analysis limited to filing headers; full impact NOT_DISCLOSED.

• ·Item 5.02 indicates officer/director change or compensatory arrangement.
• ·Item 9.01 includes financial statements and exhibits.
• ·All specifics (position, appointment/resignation, reasons) NOT_DISCLOSED.

22-12-2025

MIDDLESEX WATER CO filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but no specific details on positions, individuals, reasons, or quantitative data are provided. Analysis is limited to filing facts with all other elements NOT_DISCLOSED.

• ·Item 5.02 triggered: Officer change, election, or compensatory arrangement
• ·Filed timely on 2025-12-22 (AccNo: 0001628280-25-058529)
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

22-12-2025

Jupiter Neurosciences, Inc. filed an 8-K on December 22, 2025, disclosing officer changes or appointments (Item 5.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), submission of matters to a shareholder vote (Item 5.07), and financial statements/exhibits (Item 9.01). No specific details on positions affected, reasons for changes, quantitative data, or outcomes are provided in the summary. Analysis is constrained by lack of explicit filing content.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors with possible compensatory arrangements.
• ·Items 5.03 and 5.07 suggest governance amendments and shareholder vote results.
• ·No names, positions, reasons, or numerical data (e.g., shares, values) disclosed.

22-12-2025

Western Alliance Bancorporation filed an 8-K on December 22, 2025, under Item 5.02 disclosing a departure of directors/officers, election/appointment, or compensatory arrangements, with exhibits under Item 9.01. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. This appears to be a routine disclosure without disclosed materiality.

• ·Item 5.02 covers officer/director changes or compensatory arrangements; no names, positions, or reasons stated.
• ·Item 9.01 indicates financial statements/exhibits filed, but content NOT_DISCLOSED.
• ·Timely SEC filing (within 4 business days); no quantitative data extracted (all NOT_DISCLOSED).

22-12-2025

Covenant Logistics Group, Inc. filed an 8-K on December 22, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on positions affected, reasons, or individuals are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer-related change (departure, election, appointment, or compensation).
• ·Filed timely on 2025-12-22 per SEC requirements; no board meeting outcomes or other corporate actions mentioned.
• ·Critical details (names, positions, reasons, internal/external) NOT_DISCLOSED, limiting analysis.

22-12-2025

Scholastic Corp filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). No specifics on position, individual, appointment/resignation, reason, or quantitative data are provided in the summary. Item 9.01 lists financial statements and exhibits.

• ·Item 5.02: Generic disclosure on officer/director changes or compensatory arrangements; key details NOT_DISCLOSED
• ·Filed 2025-12-22 via US SEC; AccNo 0001193125-25-328833
• ·No quantitative data (transaction value, shares, percentages, financial metrics: all NOT_DISCLOSED); sector NOT_DISCLOSED

22-12-2025

Blackline, Inc. filed an 8-K on 2025-12-22 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). No specific details on position, individual, appointment/resignation, or reasons are provided. Item 9.01 references financial statements/exhibits, but content is NOT_DISCLOSED.

• ·Item 5.02 filing indicates officer-related event (e.g., departure, appointment, or compensation change)
• ·Filed timely (within SEC 4-business-day requirement for 8-K)
• ·No quantitative data (e.g., transaction value, share count) or specifics disclosed in provided summary

22-12-2025

ECB Bancorp, Inc. filed a Form 8-K on December 22, 2025, under Item 5.02 disclosing an officer change event involving departure, election, appointment, or compensatory arrangements. No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to metadata, indicating a routine disclosure with no material facts extracted.

• ·Item 5.02 filing: Officer change or compensatory arrangement, details NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, percentages: all NOT_DISCLOSED)
• ·Critical missing info: Position affected, reason, internal/external hire, board impact

22-12-2025

Udemy, Inc. filed a Form 8-K on December 22, 2025, under Item 5.02 disclosing a departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02: Officer/director departure, election, appointment, or compensatory arrangements (FACTS)
• ·Filed 2025-12-22; Accession No. 0001193125-25-328869 (FACTS)
• ·No names, positions, reasons, or numerical data explicitly stated (NOT_DISCLOSED)

22-12-2025

Exzeo Group, Inc. filed a Form 8-K on December 22, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary. This limits assessment of governance or market implications.

• ·Item 5.02 disclosure: Officer/director departure, election, appointment, or compensatory arrangements
• ·Filed: 2025-12-22, AccNo: 0001193125-25-328712
• ·Sector: NOT_DISCLOSED; No names, reasons, or quantitative metrics mentioned

22-12-2025

Dexcom Inc filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but no specific details on the officer, position, reason, or arrangements are provided. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Event: Officer change (Item 5.02), filed timely per SEC requirements.
• ·No details on key position (e.g., CEO/CFO), appointment/resignation, reason, or timing provided (NOT_DISCLOSED).
• ·Exhibits mentioned (Item 9.01), but contents and quantitative data NOT_DISCLOSED.

22-12-2025

AdvanSix Inc. filed an 8-K on 2025-12-22 under Item 5.02 disclosing an officer change, departure, election, appointment, or compensatory arrangement for certain officers, with exhibits under Item 9.01. No specific details on position, individual, reason, or quantitative data are disclosed in the provided summary. Analysis limited to filing headers; critical facts NOT_DISCLOSED.

• ·Item 5.02: Officer change, departure, election, appointment, or compensatory arrangements
• ·Filed 2025-12-22 (AccNo: 0001673985-25-000139)
• ·Item 9.01: Financial statements and exhibits filed; sector NOT_DISCLOSED

22-12-2025

Royalty Pharma plc filed an 8-K on 2025-12-22 under Item 5.02 disclosing a departure of directors/officers, election of directors, appointment of officers, or compensatory arrangements. No specific details on position, individual, reason, or quantitative data are provided in the summary. This appears to be a routine SEC disclosure with limited disclosed information.

• ·Item 5.02 filing confirms officer/director change event.
• ·Filed timely per SEC requirements (within 4 business days).
• ·All specifics (position, appointment/resignation, reason, quantitative data) NOT_DISCLOSED.

22-12-2025

Rexford Industrial Realty, Inc. filed an 8-K on 2025-12-22 under Item 5.02 disclosing an officer change or compensatory arrangement. No specifics on position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata; critical details NOT_DISCLOSED.

• ·Item 5.02: Departure/Election/Appointment of officers or directors; compensatory arrangements
• ·Filed 2025-12-22, AccNo: 0001571283-25-000064
• ·No names, positions, reasons, or financial metrics disclosed

22-12-2025

Impinj Inc (PI) filed an 8-K on 2025-12-22 under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements. No specifics on position, individual, reason, or quantitative details provided in the filing summary. Analysis limited to header information only.

• ·Item 5.02: Officer change or compensatory arrangements.
• ·Filed 2025-12-22, AccNo: 0001193125-25-328739.
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

22-12-2025

Oceaneering International Inc filed an 8-K on 2025-12-22 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment of Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on position, individual, reason, or quantitative data provided in the summary.

• ·Item 5.02 officer change event filed on 2025-12-22
• ·AccNo: 0000073756-25-000190, file size 258 KB
• ·Sector not specified; no names, reasons, or numbers disclosed

22-12-2025

TPG Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, nature of change (appointment or departure), reasons, or any quantitative data are provided in the filing summary. Analysis is limited to disclosure facts with all key change details NOT_DISCLOSED.

• ·Item 5.02 indicates officer or director change event, but position, type (e.g., CEO/CFO), and reason (e.g., retirement) NOT_DISCLOSED
• ·Filed timely (same day as event date) per SEC 8-K requirements (within 4 business days)
• ·No quantitative data (transaction values, shares, percentages, financial metrics) mentioned: all NOT_DISCLOSED
• ·Sector not specified; no board composition, governance, or succession details provided

22-12-2025

FactSet Research Systems Inc filed a Form 8-K on 2025-12-22 disclosing officer changes (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), results of matters submitted to shareholder vote (Item 5.07), and financial statements/exhibits (Item 9.01). No specific details on personnel changes, amendment contents, vote outcomes, or quantitative data are provided in the summary. All key facts such as positions affected, reasons, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02: Departure/appointment of directors/officers or compensatory arrangements mentioned; specifics NOT_DISCLOSED
• ·Item 5.03: Amendments to governing documents or fiscal year change; details NOT_DISCLOSED
• ·Item 5.07: Shareholder vote outcomes; results NOT_DISCLOSED
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

22-12-2025

ProFrac Holding Corp. disclosed an officer change via Form 8-K Item 5.02 on December 22, 2025. No specifics on position affected, appointment/resignation, reasons, or individuals are provided in the summary. This is a standard SEC filing for departures, elections, appointments, or compensatory arrangements of certain officers.

• ·Item 5.02 filing confirms officer-related change (departure, appointment, or compensation).
• ·No details on key position (e.g., CEO/CFO), type, reason, or timing explicitly stated.
• ·Filed per SEC requirements; sector NOT_DISCLOSED.

22-12-2025

Universal Electronics Inc filed a Form 8-K on December 22, 2025, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data are provided in the filing summary. Sector is not specified.

• ·Event pertains to Item 5.02 of Form 8-K, a standard SEC disclosure for officer/director changes.
• ·Filing date: 2025-12-22, AccNo: 0000101984-25-000245, size 140 KB.
• ·All specifics (names, positions, reasons, financials) are NOT_DISCLOSED.

22-12-2025

Flora Growth Corp. filed a Form 8-K on December 22, 2025, disclosing officer changes under Item 5.02, submission of matters to a vote of security holders under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons for changes, vote outcomes, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 covers departure/election/appointment of officers or directors and compensatory arrangements.
• ·Item 5.07 discloses shareholder vote results.
• ·Item 9.01 includes financial statements and exhibits.
• ·All specifics (positions, reasons, numbers) are NOT_DISCLOSED.

22-12-2025

RxSight, Inc. filed a Form 8-K on December 22, 2025, disclosing under Item 5.02 matters related to departure of directors/officers, elections, appointments, or compensatory arrangements; Item 7.01 Regulation FD Disclosure; and Item 9.01 Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered: Covers officer/director departures, appointments, or compensatory arrangements
• ·Item 7.01: Regulation FD Disclosure present
• ·Item 9.01: Financial Statements and Exhibits filed; AccNo 0001193125-25-328951

22-12-2025

Eos Energy Enterprises, Inc. filed an 8-K on December 22, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are provided in the summary. Quantitative data including transaction values, share counts, or financial metrics is NOT_DISCLOSED.

• ·Item 5.02 indicates officer-related change, but key details (position, individual, reason) NOT_DISCLOSED
• ·Item 9.01 references exhibits, contents NOT_DISCLOSED
• ·No board composition, succession, or governance impacts specified

22-12-2025

Patriot National Bancorp Inc disclosed an officer change via Form 8-K Item 5.02 on December 22, 2025. No specific details on the position affected, individual involved, appointment/resignation status, or reasons are provided in the summary. Quantitative data and further implications are NOT_DISCLOSED.

• ·Item 5.02 filing for officer departure, appointment, or compensatory arrangements
• ·Timely SEC disclosure (filed same day as event date)
• ·No facts on key position (e.g., CEO/CFO), reason, or board impact available